Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

This study has been completed.
Sponsor:
Information provided by:
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT01148212
First received: June 21, 2010
Last updated: February 7, 2011
Last verified: January 2011
  Purpose

Testing safety and tolerability of transcranial direct current stimulation (2 mA, 20 minutes) in four different protocols:

saline-soaked sponges electrode with electrode gel tap-water-soaked sponges tap-water-soaked-sponges + sham stimulation

Outcome measures are tolerability (comfort rating questionnaire), impedances, skin elasticity


Condition
Best Comfort and Lowest Skin Irritation

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

Further study details as provided by Ludwig-Maximilians - University of Munich:

Enrollment: 15
Study Start Date: June 2009
Study Completion Date: January 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

15 healthy volunteers

Criteria

Inclusion Criteria:

  • no neurological or psychiatric illness
  • written informed consent

Exclusion Criteria:

  • dermatologic diseases
  • medication with corticoids
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01148212

Locations
Germany
Ludwig-Maximilian-University, Dept. of Psychiatry
Munich, Germany, 80336
Sponsors and Collaborators
Ludwig-Maximilians - University of Munich
Investigators
Principal Investigator: Ulrich Palm, MD Ludwig-Maximilian-University
Study Chair: Frank Padberg, MD Ludwig-Maximilian-University
  More Information

No publications provided

Responsible Party: Ulrich Palm, MD, Ludwig-Maximilian-University Munich
ClinicalTrials.gov Identifier: NCT01148212     History of Changes
Other Study ID Numbers: 10/2009
Study First Received: June 21, 2010
Last Updated: February 7, 2011
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

ClinicalTrials.gov processed this record on August 20, 2014